T. Rowe Price Associates’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

T. Rowe Price Associates’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-952,801	Closed	-$10.8M	–	2996
2022 Q2	$10.8M	Sell	952,801 -4,442,356	-82%	-$53.3M	﹤0.01%	1311
2022 Q1	$87.6M	Sell	5,395,157 -1,953,615	-27%	-$50.1M	0.01%	772
2021 Q4	$348M	Buy	7,348,772 +2,463,847	+50%	+$148M	0.03%	420
2021 Q3	$354M	Buy	4,884,925 +4,039,773	+478%	+$292M	0.03%	413
2021 Q2	$71M	Buy	845,152 +156,332	+23%	+$10.3M	0.01%	910
2021 Q1	$33.4M	Buy	+688,820	New	+$37.4M	﹤0.01%	1142

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates's NBP Position: Q3 2022 in Review

T. Rowe Price Associates sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 952,801 shares — an estimated $10.8M sold.

T. Rowe Price Associates first reported a position in NBP in Q1 2021 and held it in 6 quarters. The position peaked at $354M in Q3 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

T. Rowe Price Associates reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
T. Rowe Price Associates sold 952,801 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $10.8M.
T. Rowe Price Associates first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 6 quarters.
T. Rowe Price Associates's NovaBridge Biosciences American Depositary Shares position peaked at $354M in Q3 2021.
75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.